At the 26th International AIDS Conference in Rio de Janeiro, researchers presented long-acting options for HIV prevention and treatment. For decades, managing HIV required taking daily pills. The new clinical findings show that less frequent doses can protect against the virus and give patients options that fit their daily lives.
For HIV prevention, trials showed that a new injectable medicine called lenacapavir gives strong protection when taken once every six months. For treatment, a new combination pill can be taken just once a week. This reduces the number of pills from 365 per year to only 52. Countries like Zambia and Zimbabwe are already introducing the six-month injection.
Health experts emphasize that flexible options are essential, especially in Africa where young women face high infection rates. However, international funding cuts have recently disrupted healthcare systems. To solve this, governments are training health workers, improving supply chains, and negotiating lower prices so these life-saving medicines become accessible to everyone.
Difficult words
- prevention — the act of stopping something bad from happening
- treatment — medical care given to help a sick person recover
- disrupt — to interrupt a system and prevent it from continuing normallydisrupted
- accessible — easy to get, use, or reach for many people
- negotiate — to talk about something to reach an official agreementnegotiating
- essential — completely necessary or extremely important for a specific purpose
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- Why might taking a pill once a week be easier for patients than taking one every day?
- What steps can governments take to ensure all patients receive necessary healthcare?
Related articles
Older adults more exposed to low-credibility online health information
Researchers at the University of Utah tracked web activity of more than 1,000 US adults for four weeks. They found low-credibility health sites were rare overall but visits were concentrated among older adults, especially those who lean right politically.
Gut has a backup system for IgA antibodies
Researchers found two different routes that make IgA antibodies in the gut. Early IgA often comes from non‑germinal center cells but later from germinal centers; both types showed similar specificity and mutations, which may help vaccine design.